CUAMC
China Universal Asset Management Company’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Buy |
10,043
+179
| +2% | +$1.97K | 0.01% | 360 |
|
|
2025
Q1 | $88.1K | Sell |
9,864
-563
| -5% | -$5.03K | 0.01% | 366 |
|
|
2024
Q4 | $98.1K | Buy |
10,427
+1,018
| +11% | +$9.58K | 0.01% | 393 |
|
|
2024
Q3 | $75.8K | Buy |
9,409
+3,696
| +65% | +$29.8K | 0.01% | 373 |
|
|
2024
Q2 | $48.4K | Sell |
5,713
-3,870
| -40% | -$32.8K | 0.01% | 358 |
|
|
2024
Q1 | $86K | Buy |
9,583
+3,824
| +66% | +$34.3K | 0.01% | 385 |
|
|
2023
Q4 | $64.7K | Buy |
5,759
+4,402
| +324% | +$49.5K | 0.01% | 341 |
|
|
2023
Q3 | $11.7K | Buy |
1,357
+600
| +79% | +$5.18K | ﹤0.01% | 338 |
|
|
2023
Q2 | $7.84K | Sell |
757
-156
| -17% | -$1.62K | ﹤0.01% | 334 |
|
|
2023
Q1 | $9.91K | Buy |
913
+229
| +33% | +$2.49K | ﹤0.01% | 295 |
|
|
2022
Q4 | $7.67K | Sell |
684
-32
| -4% | -$359 | ﹤0.01% | 251 |
|
|
2022
Q3 | $7K | Buy |
+716
| New | +$7K | ﹤0.01% | 239 |
|